Pages that link to "Q35087819"
Jump to navigation
Jump to search
The following pages link to Plasma microRNAs as potential biomarkers for non-small-cell lung cancer (Q35087819):
Displaying 50 items.
- Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies (Q24289207) (← links)
- MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment (Q26752548) (← links)
- Considering Exosomal miR-21 as a Biomarker for Cancer (Q26752550) (← links)
- Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature (Q26752611) (← links)
- Potential Role of MicroRNA-210 as Biomarker in Human Cancers Detection: A Meta-Analysis (Q26786404) (← links)
- microRNA: Diagnostic Perspective (Q26797259) (← links)
- The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids (Q26825022) (← links)
- Non-coding RNAs in lung cancer (Q26866521) (← links)
- Epigenetics of lung cancer (Q26996766) (← links)
- Micro-RNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences? (Q27005811) (← links)
- Methodological challenges in utilizing miRNAs as circulating biomarkers (Q27027950) (← links)
- Peripheral blood microRNAs: A novel tool for diagnosing disease? (Q27028196) (← links)
- Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC (Q28073562) (← links)
- AKAP4 is a circulating biomarker for non-small cell lung cancer (Q28264905) (← links)
- The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer (Q28387891) (← links)
- Circulating microRNAs in relation to EGFR status and survival of lung adenocarcinoma in female non-smokers (Q28391728) (← links)
- Circulating microRNAs are not eliminated by hemodialysis (Q28728683) (← links)
- Serum microRNA biomarkers for detection of non-small cell lung cancer (Q28731643) (← links)
- TUMIR: an experimentally supported database of microRNA deregulation in various cancers. (Q30486097) (← links)
- Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer (Q33595133) (← links)
- MicroRNA Signature of Lung Adenocarcinoma with EGFR Exon 19 Deletion (Q33776774) (← links)
- The prognostic value of miR-126 expression in non-small-cell lung cancer: a meta-analysis (Q33910531) (← links)
- Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers (Q33947851) (← links)
- microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer (Q34008192) (← links)
- MicroRNAs as lung cancer biomarkers (Q34031213) (← links)
- Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer (Q34222535) (← links)
- Serum unsaturated free Fatty acids: potential biomarkers for early detection and disease progression monitoring of non-small cell lung cancer (Q34241084) (← links)
- The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer research (Q34252557) (← links)
- MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers (Q34258717) (← links)
- Circulating miRNAs as new blood-based biomarkers for solid cancers (Q34331651) (← links)
- Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer (Q34422999) (← links)
- MicroRNA expression profiles of whole blood in lung adenocarcinoma (Q34430694) (← links)
- Serum microRNA-155 as a potential biomarker to track disease in breast cancer (Q34447755) (← links)
- Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies (Q34454908) (← links)
- Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. (Q34559564) (← links)
- Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer (Q34591159) (← links)
- Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era (Q34840130) (← links)
- Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma (Q34912903) (← links)
- Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer (Q35017119) (← links)
- Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma (Q35018941) (← links)
- Influence of plasma processing on recovery and analysis of circulating nucleic acids (Q35035846) (← links)
- A critical evaluation of microRNA biomarkers in non-neoplastic disease (Q35107632) (← links)
- Clinical Significance of MicroRNA Expression Profiles and Polymorphisms in Lung Cancer Development and Management. (Q35137739) (← links)
- Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer (Q35145235) (← links)
- Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer (Q35148262) (← links)
- Diagnostic value of microRNA-21 in the diagnosis of lung cancer: evidence from a meta-analysis involving 11 studies (Q35177139) (← links)
- Plasma microRNAs as novel biomarkers for early detection of lung cancer (Q35178184) (← links)
- Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers (Q35218751) (← links)
- Lung cancer screening: identifying the high risk cohort (Q35567559) (← links)
- Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer (Q35597752) (← links)